Reference ranges for blood tests are sets of values used by a health professional to interpret a set of medical test results from blood samples.
Reference ranges for blood tests are studied within the field of clinical chemistry (also known as "clinical biochemistry", "chemical pathology" or "pure blood chemistry"), the area of pathology that is generally concerned with analysis of bodily fluids.
Contents
|
A reference range is usually defined as the set of values 95 percent of the normal population falls within (that is, 95% prediction interval).[1] It is determined by collecting data from vast numbers of laboratory tests.
All values (except the exceptions below) denote blood plasma concentration, which is approximately 60-100% larger than the actual blood concentration if the amount inside red blood cells (RBCs) is negligible. The precise factor depends on hematocrit as well as amount inside RBCs. Exceptions are mainly those values that denote total blood concentration, and in this article they are:
A few values are for inside red blood cells only:
If not else specified, a reference range for a blood test is generally the venous range, as the standard process of obtaining a sample is by venipuncture. An exception is for acid-base and blood gases, which are generally given for arterial blood.
Still, the blood values are approximately equal between the arterial and venous sides for most substances, with the exception of acid-base, blood gases and drugs (used in therapeutic drug monitoring (TDM) assays).[4] Arterial levels for drugs are generally higher than venous levels because of extraction while passing through tissues.[4]
Reference ranges are usually given as what are the usual (or normal) values found in the population, more specifically the prediction interval that 95% of the population fall into. This may also be called standard range. In contrast, optimal (health) range or therapeutic target is a reference range or limit that is based on concentrations or levels that are associated with optimal health or minimal risk of related complications and diseases. For most substances presented, the optimal levels are the ones normally found in the population as well. More specifically, optimal levels are generally close to a central tendency of the values found in the population. However, usual and optimal levels may differ substantially, most notably among vitamins and blood lipids, so these tables give limits on both standard and optimal (or target) ranges.
In addition, some values, including troponin I and brain natriuretic peptide, are given as the estimated appropriate cutoffs to distinguish healthy people from specific conditions, which here are myocardial infarction and congestive heart failure, respectively, for the aforementioned substances.
References range may vary with age, sex, race, diet, use of prescribed or herbal drugs and stress. Standard reference ranges should theoretically not vary with the instruments and lab techniques used, but practically it may do so when inaccurate methods are used in establishing standard reference ranges. Finally, the test procedure itself may be erroneous or inaccurate.
A separate printable image is available for mass and molarity
Smaller, narrower boxes indicate a more tight homeostatic regulation when measured as standard "usual" reference range.
Units don't necessarily tell anything about molarity or mass.
A few substances are below this main interval, e.g. thyroid stimulating hormone, being measured in mU/L, or above, like rheumatoid factor and CA19-9, being measured in U/mL.
Included here are also related binding proteins, like ferritin and transferrin for iron, and ceruloplasmin for copper.
Test | Lower limit | Upper limit | Unit | Comments |
Sodium (Na) | 135,[6] 137[7][3] | 145,[7][3] 147[6] | mmol/L or mEq/L[6] | |
310,[8] 320[8] | 330,[8] 340[8] | mg/dl | ||
Potassium (K) | 3.5,[6][3] 3.6[7] | 5.0,[6][7][3] 5.1 | mmol/L or mEq/L[6] | See hypokalemia or hyperkalemia |
14[9] | 20[9] | mg/dl | ||
Chloride (Cl) | 95,[6] 98,[10] 100[3] | 105,[6] 106,[10] 110[3] | mmol/L or mEq/L[6] | |
340[11] | 370[11] | mg/dl | ||
Ionized calcium (Ca) | 1.03,[12] 1.10[3] | 1.23,[12] 1.30[3] | mmol/L | |
4.1,[13] 4.4[13] | 4.9,[13] 5.2[13] | mg/dL | ||
Total calcium (Ca) | 2.1,[6][14] 2.2[3] | 2.5,[14][3] 2.6,[14] 2.8[6] | mmol/L | |
8.4,[6] 8.5[15] | 10.2,[6] 10.5[15] | mg/dL | ||
Total serum iron (TSI) - male | 65,[16] 76[7] | 176,[16] 198[7] | µg/dL | |
11.6,[17][18] 13.6[18] | 30,[17] 32,[18] 35[18] | μmol/L | ||
Total serum iron (TSI) - female | 26,[7] 50[16] | 170[7][16] | µg/dL | |
4.6,[18] 8.9[17] | 30.4[17] | μmol/L | ||
Total serum iron (TSI) - newborns | 100[16] | 250[16] | µg/dL | |
18[18] | 45[18] | µmol/L | ||
Total serum iron (TSI) - children | 50[16] | 120[16] | µg/dL | |
9[18] | 21[18] | µmol/L | ||
Total iron-binding capacity (TIBC) | 240,[16] 262[7] | 450,[16] 474[7] | μg/dL | |
43,[18] 47[18] | 81,[18] 85[18] | µmol/L | ||
Transferrin | 190,[19] 194,[3] 204[7] | 326,[3] 330,[19] 360[7] | mg/dL | |
25[20] | 45[20] | μmol/L | ||
Transferrin saturation | 20[16] | 50[16] | % | |
Ferritin - Male | 12[21] | 300[21] | ng/mL | |
27[22] | 670[22] | pmol/L | ||
Ferritin - Female | 12[21] | 150[21] | ng/mL | |
27[22] | 330[22] | pmol/L | ||
Ammonia | 10,[23] 20[24] | 35,[23] 65[24] | μmol/L | |
17,[25] 34[25] | 60,[25] 110[25] | μg/dL | ||
Copper | 70[15] | 150[15] | µg/dL | |
11[26] | 24[26] | μmol/L | ||
Ceruloplasmin | 15[15] | 60[15] | mg/dL | |
1[27] | 4[27] | μmol/L | ||
Phosphate (HPO42−) | 0.8 | 1.5[28] | mmol/L | |
Inorganic phosphorus (serum) | 1.0[6] | 1.5[6] | mmol/L | |
3.0[6] | 4.5[6] | mg/dL | ||
Copper (Cu) | 11[29] | 24 | μmol/L | |
Zinc (Zn) | 60,[30] 72[31] | 110,[31] 130[30] | μg/dL | |
9.2,[32] 11[3] | 17,[3] 20[32] | µmol/L | ||
Magnesium | 1.5,[15] 1.7[33] | 2.0,[15] 2.3[33] | mEq/L or mg/dL | |
0.6,[34] 0.7[3] | 0.82,[34] 0.95[3] | mmol/L |
If arterial/venous is not specified for a acid-base or blood gas value, then it generally refers to arterial, and not venous which otherwise is standard for other blood tests.
Acid-base and blood gases are among the few blood constituents that exhibit substantial difference between arterial and venous values.[4] Still, pH, bicarbonate and base excess show a high level of inter-method reliability between arterial and venous tests, so arterial and venous values are roughly equivalent for these.[35]
Test | Arterial/Venous | Lower limit | Upper limit | Unit | Comments |
pH | Arterial | 7.34,[7] 7.35[6] | 7.44,[7] 7.45[6] | ||
Venous | 7.31[36] | 7.41[36] | |||
[H+] | Arterial | 36[6] | 44[6] | nmol/L | |
3.6[37] | 4.4[37] | ng/dL | |||
Base excess | Arterial & venous[36] | -3[36] | +3[36] | mEq/L | |
oxygen partial pressure (pO2) | Arterial pO2 | 10,[6] 11[38] | 13,[38] 14[6] | kPa | |
75,[6][7] 83[15] | 100,[7] 105[6] | mmHg or torr | |||
Venous | 4.0[38] | 5.3[38] | kPa | ||
30[36] | 40[36] | mmHg or torr | |||
Oxygen saturation | Arterial | 94,[36] 95,[10] 96[15] | 100[10][15] | % | |
Venous | Approximately 75[10] | ||||
Carbon dioxide partial pressure (pCO2) | Arterial pCO2 | 4.4,[6] 4.7[38] | 5.9,[6] 6.0[38] | kPa | |
33,[6] 35[7] | 44,[6] 45[7] | mmHg or torr | |||
Venous | 5.5[38] | 6.8[38] | kPa | ||
41[36] | 51[36] | mmHg or torr | |||
Absolute content of carbon dioxide (CO2) | Arterial | 23[36] | 30[36] | mmol/L | |
100[39] | 132[39] | mg/dL | |||
Bicarbonate (HCO3, ) | Arterial & venous | 18[15] | 23[15] | mmol/L | |
110[40] | 140[40] | mg/dL | |||
Standard bicarbonate (SBCe) | Arterial & venous | 21, 22[6] | 27, 28[6] | mmol/L or mEq/L[6] | |
134[40] | 170[40] | mg/dL |
Test | Patient type | Lower limit | Upper limit | Unit | Comments |
Total Protein | 60,[6] 63[7] | 78,[6] 82,[7] 84[15] | g/L | see hypoproteinemia | |
Albumin | 35[6][41] | 48,[7] 55[6] | g/L | see hypoalbuminemia | |
3.5[7] | 4.8,[7] 5.5[6] | U/L | |||
540[42] | 740[42] | μmol/L | |||
Globulins | 23[6] | 35[6] | g/L | ||
Total Bilirubin | 1.7,[43] 2,[6] 3.4,[43] 5[3] | 17,[6][43] 22,[43] 25[3] | μmol/L | ||
0.1,[6] 0.2,[7] 0.29[44] | 1.0,[6][15] 1.3,[7] 1.4[44] | mg/dL | |||
Direct/Conjugated Bilirubin | 0.0[6] or N/A[3] | 5,[6] 7[43][3] | μmol/L | ||
0[6][7] | 0.3,[6][7] 0.4[15] | mg/dL | |||
Alanine transaminase (ALT/ALAT[3]) | 5,[45] 7,[7] 8[6] | 20,[6] 21,[10] 56[7] | U/L | Also called serum glutamic pyruvic transaminase (SGPT) | |
Female | 0.15[3] | 0.75[3] | µkat/L | ||
Male | 0.15[3] | 1.1[3] | |||
Aspartate transaminase (AST/ASAT[3]) | Female | 6[46] | 34[46] | IU/L | Also called serum glutamic oxaloacetic transaminase (SGOT) |
0.25[3] | 0.60[3] | µkat/L | |||
Male | 8[46] | 40[46] | IU/L | ||
0.25[3] | 0.75[3] | µkat/L | |||
Alkaline phosphatase (ALP) | Female | 42[45] | 98[45] | U/L | |
Male | 53[45] | 128[45] | |||
(Enzyme activity) | 0.6[3] | 1.8[3] | µkat/L | ||
Gamma glutamyl transferase (GGT) | 5,[45] 8[7] | 40,[45] 78[7] | U/L | ||
Women | 0.63[47] | µkat/L | |||
Men | 0.92[47] | µkat/L |
Test | Patient type | Lower limit | Upper limit | Unit | Comments | |
Creatine kinase (CK) | male | 24,[48] 38,[7] 60[45] | 174,[15] 320[45] | U/L or ng/mL |
||
0.42[49] | 1.5[49] | µkat/L | ||||
female | 24,[48] 38,[7] 96[15] | 140,[15] 200[45] | U/L or ng/mL |
|||
0.17[49] | 1.17[49] | µkat/L | ||||
CK-MB | 0 | 3,[7] 3.8,[3] 5[45] | ng/mL or μg/L[3] | |||
Myoglobin | Female | 1[50] | 66[50] | ng/mL or µg/L | ||
Male | 17[50] | 106[50] |
Cutoffs and ranges for troponin types, 12 hrs after onset of pain | ||||
---|---|---|---|---|
Test | Lower limit | Upper limit | Unit | Comments |
Troponin-I | 0.2[51] | ng/mL or μg/L | Upper limit of normal | |
0.2[51] | 1.0[51] | ng/mL or μg/L | Acute Coronary Syndrome | |
0.4[52] | 2.0[52] | ng/mL or μg/L | Moderately increased[52] | |
1.0,[51] 1.5[53] | n/a[51][53] | ng/mL or μg/L | Myocardial Infarction likely | |
Troponin-T | 0.02[51] | ng/mL or μg/L | Upper limit of normal | |
0.02[51] | 0.10[51] | ng/mL or μg/L | Acute Coronary Syndrome | |
0.10[51] | n/a[51] | ng/mL or μg/L | Myocardial Infarction likely |
Brain natriuretic peptide (BNP) -more detailed ranges in BNP article
|
|
Interpretation | Range / Cutoff |
---|---|
Congestive heart failure unlikely | < 100 pg/mL[54][55] |
"Gray zone" | 100-500 pg/mL[54][55] |
Congestive heart failure likely | >500 pg/mL[54][55] |
NT-proBNP -more detailed ranges in NT-proBNP article
|
||
Interpretation | Age | Cutoff |
---|---|---|
Congestive heart failure likely | < 75years | > 125 pg/mL[49] |
>75 years | >450pg/mL[49] |
Test | Patient type | Lower limit | Upper limit | Unit | Therapeutic target |
Triglycerides | 10 – 39 years | 54[15] | 110[15] | mg/dL | < 100 mg/dL[56] or 1.1[56] mmol/L |
0.61[57] | 1.2[57] | mmol/L | |||
40 – 59 years | 70[15] | 150[15] | mg/dL | ||
0.77[57] | 1.7[57] | mmol/L | |||
> 60 years | 80[15] | 150[15] | mg/dL | ||
0.9[57] | 1.7[57] | mmol/L | |||
Total cholesterol | 3.0,[58] 3.6[6][58] | 5.0,[3][59] 6.5[6] | mmol/L | < 3.9[56] | |
120,[7] 140[6] | 200,[7] 250[6] | mg/dL | < 150[56] | ||
HDL cholesterol | female | 1.0,[60] 1.2,[3] 1.3[58] | 2.2[60] | mmol/L | > 1.0[60] or 1.6[58] mmol/L > 40[61] or 60[62] mg/dL |
40,[61] 50[63] | 86[61] | mg/dL | |||
HDL cholesterol | male | 0.9[60][3] | 2.0[60] | mmol/L | |
35[61] | 80[61] | mg/dL | |||
LDL cholesterol (Not valid when triglycerides >5.0 mmol/L) |
2.0,[60] 2.4[59] | 3.0,[59][3] 3.4[60] | mmol/L | < 2.5[60] | |
80,[61] 94[61] | 120,[61] 130[61] | mg/dL | < 100[61] | ||
LDL/HDL quotient | n/a | 5[3] | (unitless) |
Test | Cutoff | Unit | Comments |
Alpha fetoprotein (AFP) | 44[7] | ng/mL or µg/L | |
Beta Human chorionic gonadotrophin (bHCG) | 5[7] | IU/l or mU/ml | in male and non-pregnant female |
CA19-9 | 40[7] | U/ml | |
CA-125 | 30,[64] 35[65] | kU/L or U/mL | |
Carcinoembryonic antigen (CEA) non-smokers at 50 years |
3.4,[3] 3.6[66] | μg/l | |
Carcinoembryonic antigen (CEA) non-smokers at 70 years |
4.1[66] | μg/l | |
Carcinoembryonic antigen (CEA) - smokers | 5[67] | μg/l | |
Prostate specific antigen (PSA) | 2.5,[3] 4[7] | μg/L[7][3] or ng/mL[15] | below age 45 <2.5 μg/L |
PAP | 3[15] | units/dL (Bodansky units) | |
Calcitonin -more detailed cutoffs in Calcitonin article
|
5,[68] 15[68] | ng/L or pg/mL | Cutoff against medullary thyroid cancer[68] |
Test | Patient type | Lower limit | Upper limit | Unit |
Thyroid stimulating hormone (TSH or thyrotropin) |
Adults - standard range |
0.3,[3] 0.4,[7] 0.5,[15] 0.6[69] | 4.0,[3] 4.5,[7] 6.0[15] | mIU/L or μIU/mL |
Adults - optimal range |
0.3,[70] 0.5[71] | 2.0,[71] 3.0[70] | mIU/L or μIU/mL | |
Infants | 1.3[72] | 19[72] | mIU/L or μIU/mL | |
Free thyroxine (FT4) -more detailed ranges in
Thyroid function tests article |
Normal adult | 0.7,[73] 0.8[7] | 1.4,[73] 1.5,[7] 1.8[74] | ng/dL |
9,[75][3] 10,[76] 12[77] | 18,[3][75] 23[77] | pmol/L | ||
Child/Adolescent 31 d - 18 y |
0.8[73] | 2.0[73] | ng/dL | |
10[75] | 26[75] | pmol/L | ||
Pregnant | 0.5[73] | 1.0[73] | ng/dL | |
6.5[75] | 13[75] | pmol/L | ||
Total thyroxine | 4,[76] 5.5[7] | 11,[76] 12.3[7] | μg/dL | |
60[76][77] | 140,[76] 160[77] | nmol/L | ||
Free triiodothyronine (FT3) | Normal adult | 0.2[76] | 0.5[76] | ng/dL |
3.1[78] | 7.7[78] | pmol/L | ||
Children 2-16 y | 0.1[79] | 0.6[79] | ng/dL | |
1.5[78] | 9.2[78] | pmol/L | ||
Total triiodothyronine | 60,[7] 75[76] | 175,[76] 181[7] | ng/dL | |
0.9,[3] 1.1[76] | 2.5,[3] 2.7[76] | nmol/L | ||
Thyroxine-binding globulin (TBG) | 12[7] | 30[7] | mg/L | |
Thyroglobulin (Tg) | 1.5[76] | 30[76] | pmol/L | |
1[76] | 20[76] | μg/L |
The diagrams at right take inter-cycle and inter-woman variability into account in displaying reference ranges for estradiol, progesterone, FSH and LH.[80]
Test | Patient type | Lower limit | Upper limit | Unit |
Dihydrotestosterone | adult male | 30[81] | 85[81] | ng/dL |
Testosterone | Male, overall | 8,[82] 10[83] | 27,[82] 35[83] | nmol/L |
230,[84] 300[85] | 780[84] - 1000[85] | ng/dL | ||
Male < 50 years | 10[3] | 45[3] | nmol/L | |
290[84] | 1300[84] | ng/dL | ||
Male > 50 years | 6.2[3] | 26[3] | nmol/L | |
180[84] | 740[84] | ng/dL | ||
Female | 0.7[83] | 2.8[83] - 3.0[3] | nmol/L | |
20[85] | 80[85] - 85[84] | ng/dL | ||
17-Hydroxyprogesterone | male | 0.06[15] | 3.0[15] | mg/L |
0.18[86] | 9.1[86] | µmol/l | ||
Female (Follicular phase) | 0.2[15] | 1.0[15] | mg/L | |
0.6[86] | 3.0[86] | µmol/l | ||
Follicle-stimulating hormone (FSH) |
Prepubertal | <1[87] | 3[87] | IU/L |
Adult male | 1[87] | 8[87] | ||
Adult female (follicular and luteal phase) |
1[87] | 11[87] | ||
Adult female (Ovulation) | 6[87] 95% PI (standard) |
26[87] 95% PI) |
||
5[88] 90% PI (used in diagram) |
15[88] (90% PI) |
|||
Post-menopausal female | 30[87] | 118[87] | ||
Luteinizing hormone (LH) |
Female, peak | 20[88] 90% PI (used in diagram) |
75[88] (90% PI) |
IU/L |
Female, post-menopausal | 15[89] | 60[89] | ||
Estradiol (an estrogen) -more detailed ranges in
estradiol article |
Adult male | 50[90] | 200[90] | pmol/L |
14[91] | 55[91] | pg/mL | ||
Adult female (day 5 of follicular phase, and luteal phase) |
70[90] | 500,[90] 600[90] | pmol/L | |
19[91] | 140,[91] 160[91] | pg/mL | ||
Adult female - free (not protein bound) | 0.5[92] | 9[92] | pg/mL | |
1.7[92] | 33[92] | pmol/L | ||
Post-menopausal female | N/A[90] | < 130[90] | pmol/L | |
N/A[91] | < 35[91] | pg/mL | ||
Progesterone -more detailed ranges
in Progesterone article |
Female in mid-luteal phase (day 21-23) | 17,[88] 35[93] | 92[93] | nmol/L |
6,[88] 11[94] | 29[94] | ng/mL | ||
Androstenedione | Adult male and female | 60[89] | 270[89] | ng/dL |
Post-menopausal female | < 180[89] | |||
Prepubertal | < 60[89] | |||
SHBG -more detailed ranges
in SHBG article |
Adult female | 40[95] | 120[95] | nmol/L |
Adult male | 20[95] | 60[95] |
Test | Patient type | Lower limit | Upper limit | Unit |
Adrenocorticotropic hormone (ACTH) | 4.4[96] | 18,[97] 22[96] | pmol/L | |
20[7] | 80,[98] 100[7] | pg/mL | ||
Cortisol | 09:00 am | 140[99] | 700[99] | nmol/L |
5[100] | 25[100] | μg/dL | ||
Midnight | 80[99] | 350[99] | nmol/L | |
2.9[100] | 13[100] | μg/dL | ||
Growth hormone (fasting) | 0 | 5[6] | ng/mL | |
Growth hormone (arginine stimulation) | 7[6] | n/a | ng/mL | |
IGF-1 -more detailed ranges in
IGF-1 article |
Female, 20 yrs | 110[101] | 420[101] | ng/mL |
Female, 75 yrs | 55[101] | 220[101] | ||
Male, 20 yrs | 160[101] | 390[101] | ||
Male, 75 yrs | 48[101] | 200[101] | ||
Prolactin -more detailed ranges in
Prolactin article |
Female | 71,[102] 105[102] | 348,[102] 548[102] | mIU/L |
3.4,[102] 3.9[102] | 16.4,[102] 20.3[102] | µg/L | ||
Male | 58,[102] 89[102] | 277,[102] 365[102] | mIU/L | |
2.7,[102] 3.3[102] | 13.0,[102] 13.5[102] | µg/L | ||
Parathyroid hormone (PTH) | 10,[103] 17[104] | 65,[103] 70[104] | pg/mL | |
1.1,[3] 1.8[105] | 6.9,[3] 7.5[105] | pmol/L | ||
25-hydroxycholecalciferol (a vitamin D) -Standard reference range |
8,[15][106] 9[106] | 40,[106] 80[15] | ng/mL | |
20,[107] 23[108] | 95,[108] 150[107] | nmol/L | ||
25-hydroxycholecalciferol -Therapeutic target range |
30,[109] 40[110] | 65,[110] 100[109] | ng/mL | |
85,[56] 100[110] | 120,[56] 160[110] | nmol/L | ||
Plasma renin activity | 0.29,[111] 1.9[112] | 3.7[111][112] | ng/(mL*hour) | |
3.3,[113] 21[114] | 41[113][114] | mcU/mL | ||
Aldosterone -more detailed ranges in
Aldosterone article |
Adult | 19,[113] 34.0[113] | ng/dL | |
530,[115] 940[115] | pmol/L | |||
Aldosterone-to-renin ratio -more detailed ranges in
Aldosterone/renin ratio article |
Adult | 13.1,[116] 35.0[116] | ng/dl per ng/(mL·h) | |
360,[116] 970[116] | pmol/liter per µg/(L·h) |
Also including the vitamin B12)-related enzyme homocysteine.
Test | Patient type | Standard range | Unit | Optimal range | ||
Lower limit | Upper limit | Lower limit | Upper limit | |||
Vitamin A | 30[15] | 65[15] | µg/dL | |||
Vitamin B9 (Folic acid/Folate) - Serum |
Age > 1year | 3.0[117] | 16[117] | ng/mL or μg/L | 5[118] | |
6.8[119] | 36[119] | nmol/l | 11[119] | |||
Vitamin B9 (Folic acid/Folate) - Red blood cells |
200[117] | 600[117] | ng/mL or μg/L | |||
450[119] | 1400[119] | nmol/L | ||||
Pregnant | ng/mL or μg/L | 400[117] | ||||
nmol/L | 900[117] | |||||
Vitamin B12 (Cobalamin) | 130,[120] 160[121] | 700,[120] 950[121] | ng/L | |||
100,[122] 120[3] | 520,[122] 700[3] | pmol/L | ||||
Homocysteine -more detailed ranges in
Homocysteine article |
3.3,[123] 5.9[123] | 7.2,[123] 15.3[123] | μmol/L | 6.3[56] | ||
45,[124] 80[124] | 100,[124] 210[124] | μg/dL | 85[56] | |||
Vitamin C (Ascorbic acid) | 0.4[15] | 1.5[15] | mg/dL | 0.9[56] | ||
23[125] | 85[125] | μmol/L | 50[56] | |||
25-hydroxycholecalciferol (a vitamin D) | 8,[15][106] 9[106] | 40,[106] 80[15] | ng/mL | 30,[109] 40[110] | 65,[110] 100[109] | |
20,[107] 23[108] | 95,[108] 150[107] | nmol/L | 85,[56] 100[110] | 120,[56] 160[110] | ||
Vitamin E | μmol/L | 28[56] | ||||
mg/dL | 1.2[56] |
Test | Limit type | Limit | Unit |
Lead | Optimal health range | < 20[10] or 40[15] | µg/dL |
Ethanol | Limit for drunk driving | 0,[126] 0.2,[126] 0.8[126] | ‰ or g/L |
17.4[127] | mmol/L |
These values (except Hemoglobin in plasma) are for total blood and not only blood plasma.
Test | Patient | Lower limit | Upper limit | Unit | Comments |
Hemoglobin (Hb) | male | 2.0,[128] 2.1[6] | 2.5,[128] 2.7[6] | mmol/L | Higher in neonates, lower in children. |
130,[3] 132,[7] 135[6] | 162,[7] 170,[3] 175[6] | g/L | |||
female | 1.8,[128] 1.9[6] | 2.3,[128] 2.5[6][128] | mmol/L | Sex difference negligible until adulthood. | |
120[3][6][7] | 150,[3] 152,[7] 160[6][15] | g/L | |||
Hemoglobin in plasma | 0.16[6] | 0.62[6] | μmol/L | Normally diminutive compared with inside red blood cells | |
1 | 4 | mg/dL | |||
Glycosylated hemoglobin (HbA1c) | < 50 years | 3.6[3] | 5.0[3] | % of Hb | |
> 50 years | 3.9[3] | 5.3[3] | |||
Haptoglobin | < 50 years | 0.35[3] | 1.9[3] | g/L | |
> 50 years | 0.47[3] | 2.1[3] | |||
Hematocrit (Hct) | male | 0.39,[3] 0.4,[7] 0.41,[6] 0.45[15] | 0.50,[3] 0.52,[7] 0.53,[6] 0.62[15] | ||
female | 0.35,[3] 0.36,[6] 0.37[7][15] | 0.46,[6][7][3] 0.48[15] | |||
Child | 0.31[7] | 0.43[7] | |||
Mean cell volume (MCV) | Male | 76,[15] 82[7] | 100,[15] 102[7] | fL | Cells are larger in neonates, though smaller in other children. |
Female | 78[7] | 101[7] | fL | ||
Red blood cell distribution width (RDW) | 11.5[7] | 14.5[7] | % | ||
Mean cell hemoglobin (MCH) | 0.39[6] | 0.54[6] | fmol/cell | ||
25,[6] 27[15][3] | 32,[15] 33,[3] 35[6] | pg/cell | |||
Mean corpuscular hemoglobin concentration (MCHC) | 31,[7] 32[15][3] | 35,[7] 36[15][3] | g/dL | ||
4.8,[129] 5.0[129] | 5.4,[129] 5.6[129] | mmol/L | |||
Erythrocytes/Red blood cells (RBC) | male | 4.2,[15] 4.3[6][7][3] | 5.7,[3] 5.9,[6] 6.2,[7] 6.9[15] | x1012/L or mln/mm3 |
|
Female | 3.5,[6] 3.8,[7] 3.9[3] | 5.1,[3] 5.5[6][7] | |||
Infant/Child | 3.8[7] | 5.5[7] | |||
Reticulocytes | 26[3] | 130[3] | x109/L | ||
Adult | 0.5[6][7] | 1.5[6][7] | % of RBC | ||
Newborn | 1.1[7] | 4.5[7] | % of RBC | ||
Infant | 0.5[7] | 3.1[7] | % of RBC |
These values are for total blood and not only blood plasma.
Test | Patient type | Lower limit | Upper limit | Unit |
White Blood Cell Count (WBC.) | Adult | 3.5,[3] 3.9,[130] 4.1,[7] 4.5[6] | 9.0,[3] 10.0,[130] 10.9,[7] 11[6] |
|
Newborn | 9[131] | 30[131] | ||
1 year old | 6[131] | 18[131] | ||
Neutrophil granulocytes (A.K.A. grans, polys, PMNs, or segs) |
Adult | 1.3,[3] 1.8,[130] 2[131] | 5.4,[3] 7,[130] 8[131] | x109/L |
45-54[6] | 62,[6] 74 | % of WBC | ||
Newborn | 6[131] | 26[131] | x109/L | |
Neutrophilic band forms | Adult | 0.7[131] | x109/L | |
3[6] | 5[6] | % of WBC | ||
Lymphocytes | Adult | 0.7,[3] 1.0[130][131] | 3.5,[130] 3.9,[3] 4.8[131] | x109/L |
16-25[6] | 33,[6] 45 | % of WBC | ||
Newborn | 2[131] | 11[131] | x109/L | |
Monocytes | Adult | 0.1,[3] 0.2[132][120] | 0.8[120][131][3] | x109/L |
3,[6] 4.0 | 7,[6] 10 | % of WBC | ||
Newborn | 0.4[131] | 3.1[131] | x109/L | |
Mononuclear leukocytes (Lymphocytes + monocytes) |
Adult | 1.5 | 5 | x109/L |
20 | 35 | % of WBC | ||
CD4+ cells | Adult | 0.4,[7] 0.5[10] | 1.5,[10] 1.8[7] | x109/L |
Eosinophil granulocytes | Adult | 0.0,[3] 0.04[120] | 0.44,[120] 0.45,[131] 0.5[3] | x109/L |
1[6] | 3,[6] 7 | % of WBC | ||
Newborn | 0.02[131] | 0.85[131] | x109/L | |
Basophil granulocytes | Adult | 40[130] | 100,[120][3] 200,[131] 900[130] | x106/L |
0.0 | 0.75,[6] 2 | % of WBC | ||
Newborn | 0.64[131] | x109/L |
Test | Lower limit | Upper limit | Unit | Comments |
Thrombocyte/Platelet count (Plt) | 140,[7] 150[6][3] | 350,[15][3] 400,[6] 450[7] | x109/L or x1000/µL |
|
Mean platelet volume (MPV) | 7.4[133] | 10.4[133] | fL | |
Prothrombin time (PT) | 10,[10] 11,[6][134] 12[7] | 13,[10] 13.5,[134] 14,[7] 15[6] | s | PT reference varies between laboratory kits - INR is standardised |
INR | 0.9[3] | 1.2[3] | The INR is a corrected ratio of a patient's PT to normal | |
Activated partial thromboplastin time (APTT) | 18,[7] 30[10][3] | 28,[7] 42,[3] 45[10] | s | |
Thrombin clotting time (TCT) | 11 | 18 | s | |
Fibrinogen | 1.7,[7] 2.0[3] | 3.6,[3] 4.2[7] | g/L | |
Antithrombin | 0.80[3] | 1.2[3] | kIU/L | |
Bleeding time | 2 | 9 | minutes | |
Viscosity | 1.5[135] | 1.72[135] | cP |
Acute phase proteins are markers of inflammation.
Test | Patient | Lower limit | Upper limit | Unit | Comments |
Erythrocyte sedimentation rate (ESR) |
Male | 0 | Age÷2[136] | mm/hr | ESR increases with age and tends to be higher in females.[137] |
Female | (Age+10)÷2[136] | ||||
C-reactive protein (CRP) | n/a | 5,[138][3] 6[139] | mg/L | ||
200,[140] 240[140] | nmol/L | ||||
Alpha 1-antitrypsin (AAT) | 20,[141] 22[142] | 38,[142] 53[141] | μmol/L | ||
89,[143] 97[3] | 170,[3] 230[143] | mg/dL |
Test | Patient | Lower limit | Upper limit | Unit | Comments |
IgA | Adult | 70,[3] 110[144] | 360,[3] 560[144] | mg/dL | |
IgD | 0.5[144] | 3.0[144] | |||
IgE | 0.01[144] | 0.04[144] | |||
IgG | 800[144] | 1800[144] | |||
IgM | 54[144] | 220[144] |
Autoantibodies are usually absent or very low, so instead of being given in standard reference ranges, the values usually denote where they are said to be present, or whether the test is a positive test. There may also be an equivocal interval, where it is uncertain whether there is a significantly increased level. All included values[145] are given for the ELISA test.
Test | Negative | Equivocal | Positive | Unit |
anti-SS-A (Ro) | < 15[146] | 15-25[146] | > 25[146] | Units per millilitre (U/mL) |
anti-SS-B (La) | < 3[146] | 3 – 4[146] | > 4[146] | |
Anti ds-DNA | < 40[146] | 40 – 60[146] | > 60[146] | |
Anti ss-DNA | < 8[146] | 8 - 10[146] | > 10[146] | |
Anti-histone antibodies | < 25[146] | n/a[146] | > 25[146] | |
Cytoplasmic/classical anti-neutrophil cytoplasmic antibodies (c-ANCA) |
< 20[146] | 21 - 30[146] | > 30[146] | |
Perinuclear anti-neutrophil cytoplasmic antibodies (p-ANCA) |
< 5[146] | n/a | > 5[146] | |
Anti-mitochondrial antibodies (AMA) | < 10[146] | n/a[146] | > 10[146] | |
Rheumatoid factor (RF) | < 20 | 20 - 30 | > 30[7] | |
Antistreptolysin O titre (ASOT) in preschoolers |
> 100 | |||
ASOT at school age | > 250[7] | |||
ASOT in adults | > 125[7] |
Test | Negative | Low/weak positive | Moderate positive | High/strong positive | Unit |
Anti-phospholipid IgG | < 20[146] | 20 –30[146] | 31 – 50[146] | > 51[146] | GPLU/ml[146] |
Anti-phospholipid IgM | < 1.5[146] | 1.5 –2.5[146] | 2 – 9.9[146] | > 10[146] | MPL /ml[146] |
Anti-phospholipid IgA | < 10[146] | 10 -20[146] | 21 – 30[146] | > 31[146] | arb U/ml[146] |
Anti-citrullinated protein antibodies | < 20[146] | 20 – 39[146] | 40 - 59[146] | > 60[146] | EU[146] |
Test | Lower limit | Upper limit | Unit | Comments |
Lactate dehydrogenase (LDH) | 50[15] | 150[15] | U/L | |
0.4[45] | 1.7[45] | μmol/L | ||
1.8[3] | 3.4[3] | µkat/L | < 70 years old[3] | |
Amylase | 25,[6] 30,[7] 53[15] | 110,[7] 120,[147] 123,[15] 125,[6] 190[45] | U/L | |
0.15[3] | 1.1[3] | µkat/L | ||
200[140] | 240[140] | nmol/L | ||
D-dimer | n/a | 500[148] | ng/mL | Higher in pregnant women[149] |
0.5[3] | mg/L | |||
Lipase | 7,[7] 10,[15] 23[45] | 60,[7] 150,[15] 208[45] | U/L | |
Angiotensin-converting enzyme (ACE) | 23[45] | 57[45] | U/L | |
Acid phosphatase | 3.0[45] | ng/mL | ||
Eosinophil cationic protein (ECP) | 2.3[3] | 16[3] | µg/L |
Electrolytes and Metabolites: For iron and copper, some related proteins are also included.
Test | Patient type | Lower limit | Upper limit | Unit | Comments |
Osmolality | 275,[6] 280,[15] 281[3] | 295,[6] 296,[15] 297[3] | mOsm/kg | Plasma weight excludes solutes | |
Osmolarity | Slightly less than osmolality | mOsm/l | Plasma volume includes solutes | ||
Urea | 1.2,[6] 3.0[150] | 3.0,[6] 7.0[150] | mmol/L | BUN - blood urea nitrogen | |
7[6] | 18,[6] 21[7] | mg/dL | |||
* Uric acid[7] | 0.18[6] | 0.48[6] | mmol/L | ||
Female | 2.0[15] | 7.0[15] | mg/dL | ||
Male | 2.1[15] | 8.5[15] | mg/dL | ||
Creatinine | male | 60,[3] 68[151] | 90,[3] 118[151] | μmol/L | May be complemented with creatinine clearance |
0.7,[152] 0.8[152] | 1.0,[152] 1.3[152] | mg/dL | |||
female | 50,[3] 68[151] | 90,[3] 98[151] | μmol/L | ||
0.6,[152] 0.8[152] | 1.0,[152] 1.1[152] | mg/dL | |||
BUN/Creatinine Ratio | 5[15] | 35[15] | - | ||
Plasma glucose (fasting) | 3.8,[6] 4.0[3] | 6.0,[3] 6.1[153] | mmol/L | See also glycosylated hemoglobin (in hematology) | |
65,[7] 70,[6] 72[154] | 100,[153] 110[15] | mg/dL | |||
Full blood glucose (fasting) | 3.3[3] | 5.6[3] | mmol/L | ||
60[154] | 100[154] | mg/dL | |||
Lactate (Venous) | 4.5[15] | 19.8[15] | mg/dL | ||
0.5[155] | 2.2[155] | mmol/L | |||
Lactate (Arterial) | 4.5[15] | 14.4[15] | mg/dL | ||
0.5[155] | 1.6[155] | mmol/L | |||
Pyruvate | 300[15] | 900[15] | μg/dL | ||
34[156] | 102[156] | μmol/L |
|